Blockchain, Data mining, and Disruptive Technologies: Digital Innovations in Clinical Research

In the last decade, innovations in data technology have greatly contributed to the quality and transparency of clinical research. System security, clinical trial design, and data analysis are some of the areas which have seen significant modernisation to keep up...

2 days ago
Bioinformatics,AI & ML,Biology,News

Blockchain, Data mining, and Disruptive Technologies: Digital Innovations in Clinical Research

In the last decade, innovations in data technology have greatly contributed to the quality and transparency of clinical research. System security, clinical trial design, and data analysis are some of the areas which have seen significant modernisation to keep up...

2 days ago

Implementation of Machine Learning in Drug Development

Significant recent investment in computational technology has seen a number of new innovations arise in drug discovery - perhaps most notable machine learning (ML). By 2022, it is expected that AI technology will contribute $2.199 billion to pharma’s revenue, with...

4 days ago
Bioinformatics,AI & ML,Biology

Implementation of Machine Learning in Drug Development

Significant recent investment in computational technology has seen a number of new innovations arise in drug discovery - perhaps most notable machine learning (ML). By 2022, it is expected that AI technology will contribute $2.199 billion to pharma’s revenue, with...

4 days ago

Predicting Drug Toxicity: Challenges and Innovations

Failure to reach the desired safety profile is one of the main reasons for delayed drug development. Advancements in preclinical studies have seen the optimisation of in vitro assays to better predict toxicity in drug discovery. Computational methods like in...

6 days ago
Pharmacovigilance,Biomanufacturing,Biology,News

Predicting Drug Toxicity: Challenges and Innovations

Failure to reach the desired safety profile is one of the main reasons for delayed drug development. Advancements in preclinical studies have seen the optimisation of in vitro assays to better predict toxicity in drug discovery. Computational methods like in...

6 days ago

Targeting RNA: A Key Part of Disease Research and Therapeutic Developments

Ribonucleic acid (RNA) has proven in the last decade to be a valid therapeutic target for a multitude of diseases. The ability to manipulate the genetic code to produce almost any protein is one of the many advantages that has...

1 week ago
R&D,Biology,News

Targeting RNA: A Key Part of Disease Research and Therapeutic Developments

Ribonucleic acid (RNA) has proven in the last decade to be a valid therapeutic target for a multitude of diseases. The ability to manipulate the genetic code to produce almost any protein is one of the many advantages that has...

1 week ago

Real World Data and Evidence: Emerging Trends Across Clinical Research

Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...

1 week ago
Bioinformatics,Clinical Operations,Biology,News

Real World Data and Evidence: Emerging Trends Across Clinical Research

Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...

1 week ago

Disease Models and Target Validation: An Interview with Professor Gavin Woodhall

In a recent interview with Proventa, Professor Gavin Woodhall, research scientist and Head of Neuroscience at Aston University, discussed the challenges of modelling human disease and the impact of alternative models on target validation. Professor Woodhall has an extensive academic...

2 weeks ago
R&D,Biology,News

Disease Models and Target Validation: An Interview with Professor Gavin Woodhall

In a recent interview with Proventa, Professor Gavin Woodhall, research scientist and Head of Neuroscience at Aston University, discussed the challenges of modelling human disease and the impact of alternative models on target validation. Professor Woodhall has an extensive academic...

2 weeks ago

An Evaluation of Data Capture and Visualization in Clinical Research

Data capture and visualization are the key components of clinical trial data analysis. However, with the explosion of COVID-19 around the world, data collection became difficult with poor patient recruitment and a reduction in face-to-face clinics. Advancements in telehealth have...

3 weeks ago
Bioinformatics,Biology,News

An Evaluation of Data Capture and Visualization in Clinical Research

Data capture and visualization are the key components of clinical trial data analysis. However, with the explosion of COVID-19 around the world, data collection became difficult with poor patient recruitment and a reduction in face-to-face clinics. Advancements in telehealth have...

3 weeks ago

Challenges of Modelling Human Disease – Optimising Target Validation

The complexity of the human body presents a challenge when choosing a model that is translatable and can also be manipulated for target validation. In addition to the popular animal models, recent innovations in computational biology has seen significant advancements...

3 weeks ago
R&D,Biology

Challenges of Modelling Human Disease – Optimising Target Validation

The complexity of the human body presents a challenge when choosing a model that is translatable and can also be manipulated for target validation. In addition to the popular animal models, recent innovations in computational biology has seen significant advancements...

3 weeks ago

Innovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases

Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...

3 weeks ago
Oncology,R&D,Clinical Development,Precision and Personalised Medicine,Biology,News

Innovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases

Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...

3 weeks ago

Discovering Novel Chemical Entities with DNA-Encoded Libraries: Promises and Pitfalls

Early drug discovery in the pharmaceutical industry has driven the development of technology to create large libraries of compounds for screening of chemical targets. Innovations in DNA-encoded libraries have been critical in optimising drug discovery, demonstrating greater selectivity of hit...

1 month ago
R&D,Biology

Discovering Novel Chemical Entities with DNA-Encoded Libraries: Promises and Pitfalls

Early drug discovery in the pharmaceutical industry has driven the development of technology to create large libraries of compounds for screening of chemical targets. Innovations in DNA-encoded libraries have been critical in optimising drug discovery, demonstrating greater selectivity of hit...

1 month ago